Future technology for continuous renal replacement therapies

Claudio Ronco, Rinaldo Bellomo, Mary Lou Wratten, Giro Tetta

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)


Critically ill patients are increasingly treated with continuous hemofiltration and derived techniques, now grouped under the term of continuous renal replacement therapy (CRRT). CRRT can provide adequate blood purification and correction of electrolyte derangements. They also seem to prevent further injury to the patient by maintaining a stable level of homeostasis. Recently, newer indications have been proposed for CRRT, including the treatment of neonates, patients with heart disease, and septic patients. It has been hypothesized that continuous therapies might contribute to the removal of noxious substances in the middle molecular-weight range, such as cytokines or autocoids. According to these new indications, technical developments are making available new forms of treatment, new materials, and specially designed machines.

Original languageEnglish
Pages (from-to)S121-S129
Number of pages9
JournalAmerican Journal of Kidney Diseases
Issue number5 SUPPL. 3
Publication statusPublished - 1 Jan 1996
Externally publishedYes


  • acute renal failure
  • continuous therapies
  • hemodialysis
  • Hemofiltration
  • sepsis

Cite this